Search results for: 'disease management program'

This Frost & Sullivan research service focuses on US Department of Defense (DoD) command, control, communications, computers, intelligence, surveillance, and reconnaissance (C4ISR) budget spending. The study includes research, development, test, and evaluation (RDT&E); procurement; operations and maintenance (O&M); and other services. C4ISR spe...

23 Jun 2016  |  North America  |  Market Research

Growth Opportunities in the US Point-of-care Testing Market

Digital Health Meets Point of Care—Emergence of Mobile Molecular Diagnostics

Infographics

×

The US point-of-care testing (POCT) study provides an extensive analysis for 13 segments: hematology, urinalysis, infectious disease, cardiac, HbA1c, glucose, fecal occult blood test/fecal immunochemical test (FOBT/FIT), coagulation PT/INR, coagulation APTT/ACT, cholesterol, pregnancy, drugs of abuse, and blood gas and electrolytes. Key trends and ...

Monoclonal antibody therapeutics are being used for treatment of a wide array of diseases, specially in therapeutic areas such as oncology, immunology (including autoimmune and inflammatory diseases, as well as, transplant rejection) and neuroscience. The development of these new molecular agents, successfully directed to specific cellular targets,...

The Russian wound care market is in growth stage. Regulatory changes, growing economy, increasing awareness and medical tourism are likely to support penetration. This research service provides details about funding pattern, disease prevalence, procurement proccess, distribution structure, market share analysis, pricing analysis, revenue forecasts ...

This research service analyses the trends in the women's incontinence and osteoporosis markets in Europe, strategically, by evaluating the various forces that are currently shaping this maturing market. It analyses the key segments in this market, namely, disease prevalence and characteristics, geographic analysis, key industry trends and current t...

This study highlights emerging companies in the cardiovascular space. Cardiovascular disease detection and monitoring have been gaining significant attention considering rising healthcare costs and challenges related to the availability of a skilled healthcare workforce. Companies are trying to address these challenges with technology-driven so...

07 Mar 2023  |  Global  |  Technology Research

Global Gut Microbiome Growth Opportunities

Targeted Gut Microbiome Technologies to Drive Transformational Growth Across the Global Healthcare Landscape

Infographics

×

This study identifies and analyzes research initiatives focused on the development of gut microbiome therapeutics. Disruption of the gut microbiome causes a range of health issues, including gastrointestinal diseases, immuno-oncological diseases, and metabolic diseases. Over the last decade, gut microbiome therapeutics have largely relied on untarg...

17 Feb 2025  |  Global  |  Technology Research

Emerging Technologies for Salt and Fat Reduction in Food and Beverage Products, Forecast to 2029

Increased Focus on Health and Wellness Promoting the Implementation of Salt and Fat Reduction Technologies

Infographics

×

Cardiovascular disease, obesity, and other lifestyle diseases are either caused or aggravated by consumption of highly processed food products with large quantities of added salt and fat ingredients that are added to improve flavor and extend shelf life. More and more consumers are demanding reductions in salt and fat content, food and safety orga...

The story for 2024 is artificial intelligence (AI). Businesses across industries are scrambling to determine how they can leverage AI, particularly generative AI (GenAI), to meet their business goals. Public cloud providers are at the forefront of the effort to accelerate AI adoption among customers by developing foundational models and user-friend...